The risks of cardiovascular disease related to obesity can be managed via intentional weight loss. Obesity and cardiovascular disease (CVD) are each considered a chronic health condition by the World Obesity Federation, a group that has partnered with the World…
When patients stop taking semaglutide, health care providers should prepare them for possible withdrawal symptoms such as weight regain, increased appetite and food cravings, and the re-emergence of cardiovascular and metabolic risk factors. Semaglutide is an effective pharmacotherapy for helping…
Modifiable health behaviors such as dietary interventions and recognizing hypertension behavioral symptoms could help reduce risks of hypertension for adults with obesity. If current trends continue, there could be a 16.4 percent increase in adults with obesity by 2030.1…